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Adaptation of Three Different Apoptotic Methods in Equine 
Bronchoalveolar Cells and Comparison of Bronchoalveolar Lavage 
Cell Apoptosis in Normal and COPD Affected Horses Before and 
After Dexamethasone Administration 
 
Teri L. Leichner, DVM 
(ABSTRACT) 
 
Recent studies suggest that lymphocyte apoptosis serves to regulate pulmonary 
inflammation.  Equine COPD, an allergic disease of the lower airway, is likely 
due to dysregulation of the pulmonary immune response. In this study, the 
hypothesis tested was COPD affected horses would have less apoptotic airway 
lymphocytes than control horses during clinical disease. To achieve this, 3 
methods of measuring apoptosis, Vindelov’s propidium iodide with Triton-X 
(PI/Triton-X), 7-aminoactinomycin D (7-AAD), and Annexin V with propidium 
iodide (Annexin/PI) were evaluated in equine airway lymphocytes. A significant 
linear relationship was found for equine bronchoalveolar lavage (BAL) 
lymphocytes stained with 7-AAD and Annexin/PI .  No relationship was 
identified with cells stained with PI/Triton-X and Annexin/PI, and 7-AAD and 
PI/Triton-X indicating that methods which preserve cell membrane characteristics 
are more comparable when measuring BAL lymphocytes apoptosis in a 
heterogeneous population of cells.  Additionally, all stains appear to perform the 
same in COPD and normal horses in remission and disease. 
 
Comparison of predominately BAL lymphocyte apoptosis using the above 
methods were performed at baseline, after natural challenge, and after 
dexamethasone administration in nine horses, five of which were affected with 
COPD.  No differences in bronchoalveolar lavage lymphocyte apoptosis between 
COPD and control horses were detected either before or after dexamethasone 
administration, although numerical trends in COPD horses identified less   iii
apoptosis after natural challenge indicating that defective apoptosis may play a 
role in equine COPD pathogenesis.  Dexamethasone administration was 
associated with trends of improvement in the pulmonary gas exchange and 
increased apoptosis toward baseline in the COPD horses.   
 
Funding for this research was granted from the American Association of Equine 
Practitioners, the Comparative Respiratory Society, and the Companion Animal 
Research Focus Unit at Virginia-Maryland Regional College of Veterinary 
Medicine.   
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Introduction: 
Equine chronic obstructive pulmonary disease (COPD) is a disease characterized by wheezing, 
coughing, and bronchial hyper-reactivity when the horse is exposed to various antigens.  The 
American Thoracic Society identified the horse as a possible natural model for studying human 
asthma as the two diseases share many clinical similarities.  Additionally, human asthmatics 
have been found to have decreased bronchial lavage T lymphocyte apoptosis (cell death) when 
exposed to antigens as measured by different apoptotic methods. 
 
Methods available to identify apoptosis in cells are numerous.  Methodologies to identify DNA 
fragmentation, cell wall asymmetry, and apoptotic bodies are available.  Many have been 
adapted to species other than humans (Chapter 2).  Three methods, 7-aminoactinomycin-D (7-
AAD), Annexin-V/Propidium Iodide (Annexin/PI), and Propidium Iodide with Triton-X 
(PI/Triton-X), were chosen for investigation of adaptation and comparison in detecting apoptosis 
in equine bronchoalveolar lavage retrieved lymphocytes because of their relative ease of 
application and previous history of adaptation in mice, fish and birds. 
 
Treatment of equine COPD can include inhalant or parenteral administration of corticosteroids to 
suppress the pulmonary inflammation.  Glucocorticoids like dexamethasone have been found to 
induce apoptosis in murine thymocytes and human peripheral blood lymphocytes.  Apoptosis 
induction in lymphocytes might be one way that pulmonary inflammation is decreased in human 
asthmatics when corticosteroids are administered and might be one mechanism that helps to 
eliminate inflammation in equine COPD.  Therefore, comparisons of apoptosis percentages using 
7-AAD, Annexin/PI, and PI/Triton-X staining methods were performed at baseline, after natural 
challenge, and after dexamethasone therapy to investigate any differences (Chapter 3). 
 
To understand the processes involved in apoptosis and regulation of an immune response, a 
review is provided of apoptotic mechanisms and attenuation of an immune response, focusing on 
equine COPD, human asthma and corticosteroids (Chapter1).  2
Chapter 1:  
A. Pulmonary Immunology  
 
The lung is an organ that is continually assaulted with foreign material that is encountered with 
every breath that an animal takes.  The pulmonary system has evolved a defense structure that 
helps it to cope with the onslaught of particles while minimizing the amount of inflammation.  
The upper airways provide the first line of defense to large (>10 microns), inhaled particles.  
Larger particles are likely to be impeded in the hairs of the nasal passages and by collision on the 
airway walls (Twigg 1998).  Mid-sized particles (5 – 10 microns) may make it past the upper 
airways and into the tracheobronchial tree.  Here they are also likely to impact on the lower 
airway walls and be cleared by the mucociliary escalator mechanism.  Coughing is also an 
effective mechanism that can help to clear the tracheobronchial tree of debris.   
 
Inertial impaction is the predominent means of deposition for particles larger than 5 microns 
traveling at high velocities, as would occur in the upper airway and conducting bronchi 
(Buechner-Maxwell 1993).  Other sources of eliminating small particles (< 5 microns) that may 
invade deeper into the airways include gravitational sedimentation and Brownian diffusion 
(Buechner-Maxwell 1993).  Gravitational sedimentation involves gravitational forces ‘pulling’ 
the particle into the airway wall and occurs with near zero airflow velocities.  Brownian diffusion 
occurs with very small (<0.5 microns) particles when random gas molecules displace the particle 
into the airway wall.  Particles less than 5 microns, like bacteria, which are able to reach the 
alveolar space, are then cleared by immune mechanisms versus the aforementioned mechanical 
mechanisms of the airways.    
 
Immune mechanisms that the pulmonary tree uses to rid itself of foreign material include both 
innate and acquired defenses.  The pulmonary innate immune system involves phagocytic cells 
with other non-cellular mechanisms.  The alveolar macrophage is very important in the 
homeostasis of the pulmonary immune system with it having phagocytic and secretory functions.  
The alveolar macrophage is also the most prominent cell in bronchoalveolar lavage fluid 
representing up to 60% of the cellular population from the lower respiratory tract of the horse 
(Rush-Moore 1996).      3
 
The three primary functions of the alveolar macrophage are intracellular killing, antibody 
dependent mediated cytotoxicity and antigen processing/presentation to T helper cells.  The 
alveolar macrophage has many mechanisms in which to phagocytise foreign proteins.  Sugar 
receptors like mannosyl-fucosyl receptor (MFR) and N-acetyl glucosamine bind surface sugars 
on foreign proteins, CD14 (lipopolysaccharide binding protein receptor) coats gram negative 
bacteria, and 3 distinct Fc receptors for IgG which can trigger extracellular killing and aid in 
phagocytosis of opsonized bacteria are present (Roitt 1998).  The alveolar macrophage is able to 
generate toxic oxygen species like superoxide anion, hydrogen peroxide and hydroxyl radicals 
that function to destroy foreign proteins.  Additionally, many preformed proteases within the 
alveolar macrophage can degrade the extracellular matrix of offending bacteria (Liew 1991).   
Alveolar macrophages also have receptors that aid in cellular adhesion (CR1) and activation 
(CD23, IgE receptor, IL receptors). 
   
Products of activated alveolar macrophages include complement components (C5a), fibrinolytic 
fragments, interleukin-8 (IL-8), interleukin-1 (IL-1) and arachidonic acid metabolites like 
leukotriene B4.  These cytokines not only attract other phagocytic cells like polymorphonuclear 
cells (PMN), but can stimulate lymphocytes too.  PMN’s are not normally found in human BAL 
fluid (Gratziou 1991) and comprise less than 5% of cells in horse BAL fluid (Mair 1987, 
Sweeney  1991).  PMN’s exert their killing effect by releasing lysosomes, granules that contain 
acid hydrolases, myeloperoxidases, and muramidase (lysozyme), into their surrounding areas.  
PMN’s also contain lactoferrin, an iron chelator, that keeps this vital nutrient away from 
multiplying bacteria.  Other less specific defense mechanisms used by PMN’s  to phagocytise 
and kill include defensins, seprocidins, cathelicidins, and bacterial permeable inducing protein 
(Roitt 1998).   
 
Eosinophils are another granulocytic cell, much like the PMN, that are attracted by products of 
the alveolar macrophage.  Eosinophils are believed to have an important role in parasitic 
infestations and allergic disease.  Adherence to third stage larvae of Strongylus vulgaris (Klei  
1992) has been documented in equine eosinophils.  Like the PMN, eosinophils contain cytotoxic 
proteins that are used to destroy foreign antigen upon stimulation and resultant respiratory burst.    4
Equine eosinophils contain eosinophil peroxidase (Klebanoff 1989) and four basic proteins with 
one similar to human basic protein (Piller 1993) that are used in extracellular killing.  Foster and 
coworkers (1998) identified a biologically active alkaline phosphatase that aids in generation of 
large amounts of superoxide anions used in the respiratory burst killing effect.  Interleukin-5, a 
product of activated T helper 2 cells, attracts eosinophils to sites of inflammation.  Degranulation 
of eosinophils results in damage to surrounding tissue, like respiratory epithelium.  This may 
facilitate antigen entry and increase bronchial inflammation and bronchoconstriction. 
 
Any residual foreign proteins that the innate immune defense mechanisms are not able to 
completely clear then activates the acquired pulmonary immunity.  This system involves 
B lymphocytes and dendritic cells, which along with macrophages, are able to present 
processed antigen to T lymphocytes.  Antigen processing by the antigen presenting cells 
(APC) involves cleavage of the antigen into smaller peptide fragments, synthesis of the 
major histocompatability class II  (MHC) in the rough endoplasmic reticulum and 
binding of the peptide to the MHC class II molecule.  The MHC class II – peptide 
molecule is then expressed on the surface of the cell for interaction with the T helper 
cells.  
 
 Dendritic cells are one of the more effective APC in the lung.  Dendritic cells reside 
mainly in the bronchial walls and alveolar wall (Sertl 1986), although up to 0.4% of cells 
recovered from bronchoalveolar lavage fluid are dendritic cells (van Haarst 1994).  
Recently, 2 - 4% of peripheral leukocytes in humans were determined to be dendritic 
cells (Crawford 1999).  Dendritic cells are perfectly situated to encounter and trap foreign 
antigen because of where they reside.  Immature dendritic cells then traffic back to lymph 
nodes to induce allogenic T cell responses.  They are potent producers of IL – 12; a 
cytokine capable of increasing B cells and Type 1 T cell response.  
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T cell Organization: 
The population of T lymphocytes can be divided into cells expressing either CD4
+ or 
CD8
+ surface molecules.  CD8+ cells are called cytotoxic T cells and CD4+ cells are 
called T helper cells.  CD4+ T cells are further grouped into Type 1 (Th1) or Type 2 
(Th2) cells depending on the cytokines that they elaborate.  Th1 cells secrete interleukin 
– 2 (IL-2), interferon gamma (INFγ), and tumor necrosis factor – beta (TNFβ) while Th2 
cells secrete interleukin – 4 (IL-4), IL-5, IL-10, and IL-13.  IL-2 and IL-4 stimulate the B 
cell to enlarge and divide while IL-5 stimulates the B cell to transform into a antibody 
secreting plasma cell.   
 
This pool of T helper and T cytotoxic cells can also be divided into naïve, effector and 
memory subsets.  Maintenance of naïve CD4
+ and CD8
+ T cells depends on low level 
exposure to MHC class II and MHC class I, respectively (Tanchot 1997, Markiwicz  
1998).  Maintenance of memory T cells is as yet, unexplained.  It has been proposed that 
memory T cell survival is dependent on cross reactive peptide recognition (Beverley  
1990).  Maintenance of the total population of T cells and their respective subsets are 
actively controlled (Tanchot 1997).  Activation of effector T cells may cause a huge 
clonal expansion, followed by massive apoptosis once the need is gone (Maini 1999).  
The naïve and memory T cell subsets are maintained at a fairly constant size.   The active 
control of these subsets allows diversity among the different pools.  If one subset, i.e. 
memory cells, were to survive better and accumulate resulting in less naïve cells 
surviving, this could restrict immunologic diversity.  Likewise, if naïve cells were to 
accumulate over memory cells, the immune system may lack versatility to respond to 
various antigens.  This is solved at least in the peripheral pool of cytotoxic T cells by 
having two compartments of equal size.  It is unknown if T helper cells follow this same 
strategy.   
 
T Helper Cell Activation:  
Naïve CD4 T cells continuously migrate through the body and lymphoid organs.  
Lymphoid organs are where most naïve lymphocytes first encounter antigen 
(Westermann 1999).  Activation of T cells involves coupling of the T cell receptor   6
 
 
 
 
 
 
(TCR), a heterodimer of two polypeptide chains with foreign antigen.  The TCR does not 
bind free antigen, but rather recognizes foreign antigen along with the major 
histocompatibility complex (MHC) on an antigen presenting cell (APC).  The TCR is 
closely associated with CD3, a collection of polypeptide chains that are expressed on all 
T cells and aid in signal transduction. Binding of the CD4 molecules on the T cells to the 
non-polymorphic region of the MHC on the APC, along with interactions between other 
costimulatory or adhesion molecules, triggers T cell activation.  
  
Figure 1: T Cell activation and antigen presentation 
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T Cell Homing: 
T cells first encounter antigen in lymphoid tissue like lymph nodes and Peyers patches.  
Immigration of T cells through the lymphoid tissue involves using high endothelial 
venules.  Activated lymphocytes have been observed to accumulate preferentially in the 
original tissue where first activation took place (Bode 1997, Westermann 1999).  
Accumulation of activated T cell in tissues was speculated to be caused by preferential 
entry, increased proliferation and reduced death, reduced exit rate or a combination of the 
three.  Preferential entry was determined not to be a factor when similar entry rates were 
observed in two different sources of activated T cells into a lymph node.  These same two 
pools of activated T cells were found to have similar kinetics of movement into and out 
of lymph nodes negating decreased rate of exit as a possibility.  Preferential proliferation 
and reduced apoptosis was identified as causes of accumulation of activated T cells in the 
tissue of origin (Bode 1997, Westermann 1999).   
 
 
B. Regulation of the Pulmonary Immune Response 
 
Apoptosis is a regulated and physiologic event.  Apoptosis naturally occurs everyday in 
embryonic development, new tissue growth, hormone dependent involution, and immune 
system development.  It is seen in varied amounts in many pathologic conditions like 
AIDS, Alzheimers, autoimmune disease, and cancer (Allen 1997).   
 
Apoptosis is a complex event in cells that is triggered by internal mechanisms.   Initiation 
of apoptosis results in redistribution of cell membrane phospholipids, cell shrinkage, 
endonuclease activation and DNA fragmentation (Squier 1995). Very early in apoptosis, 
plasma membrane changes occur that identify the apoptotic cell to phagocytes.  The 
translocation of the phospholipid, phosphatidylserine, from the inner leaflet of the plasma 
membrane to the membrane surface is one such early recognition factor (Fadok 1992).  
Other cell surface molecules that may aid in early recognition have been identified   8
(Haslet 1994, Saville 1989,1990).  Possibly concurrently or immediately after plasma 
membrane changes, DNA fragmentation begins.  Initial cleavage of DNA into 50 to 300 
kilobase pairs and then internucleosomal cleavage with formation of fragments 
containing 180 – 200 base pairs occurs (Oberhammer, 1993).   
 
Morphologically, the earliest changes that can be visualized is nuclear chromatin 
condensation to form dark, crescentric masses (Wyllie, 1987).  Concurrent cell shrinkage 
due to inhibition of the Na
2+–K
1+- Cl
1- cotransport system and net external fluid 
movement begins (Wilcock 1988).  Blebbing of both nuclear and plasma membranes 
develops due to cell shrinkage.  Nuclear fragments within cytoplasmic fragments are 
produced by the extensive shrinkage and blebbing of membranes and are termed 
‘apoptotic bodies’.  Crosslinkage of cytoplasmic proteins by tissue transglutaminase 
(tTG) (Fesus 1991) helps to keep intracellular contents within the cell or apoptotic body 
thereby eliminating an inflammatory response due to spillage of proinflammatory 
mediators from the dying cell.   
  
Apoptosis differs from other processes like oncosis and necrosis.  Oncosis refers to initial 
swelling of the cell after death has occurred.  Necrosis is the after effect of oncosis, 
occurring long after cell death.  Necrosis is characterized by the many cells involved, 
cellular swelling, karyolysis, disrupted cytoplasmic organelles, blebbing and loss of cell 
membrane integrity resulting in inflammation.  With the loss of the cell membrane, many 
pro-inflammatory mediators are released into the local and systemic environment.  This 
in turn promotes cellular influx and possible amplification of the inflammation.  Unlike 
necrosis, the shrinkage of the cell in the apoptosis process results in retention of the pro-
inflammatory mediators.  Apoptosis, therefore, terminates an inflammatory response. 
 
Apoptotic Signals: 
The body uses many mechanisms to terminate an immune response.  Tolerance is a 
mechanism where the body shows immunologic unresponsiveness to specific foreign 
proteins.  Tolerance is induced by prior exposure to an antigen and is very important in 
areas like the gastrointestinal and respiratory tracts that continually encounter innocuous   9
antigens.  It is also the mechanism that the body uses so that our own immune system 
does not destroy our body.  Anergy, a result of lack of co-stimulatory signals, can occur 
with persistent tolerance in T helper cells. Apoptosis, another mechanism, results in cell 
suicide or a programmed cell death. 
 
Apoptosis can result from an intrinsic and extrinsic pathway.  The intrinsic pathway 
involves the release of cytochrome c from the mitochondria of the cell that is induced 
from various signals like elevations of pro-apoptotic proteins in the Bcl-2 family.  
Cytochrome c then stimulates a cascade that eventually induces caspase-9 activation and 
results in apoptosis.  The extrinsic pathway can be induced by members of the tumor 
necrosis factor family receptors like Fas.  These proteins then recruit other effector 
proteins which results in activation of caspase–8 and apoptosis through a final common 
pathway.         
 
Figure 2: Extrinsic and Intrinsic Pathways for Apoptosis 
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Fas ligand (FasL) is a type II membrane protein in the tumor necrosis factor (TNF) 
family (Suda 1993, Nagata 1995) and is expressed predominately on activated T cells.  
Binding of FasL to its receptor, Fas, begins the process of apoptosis.  The TNF family 
includes lymphotoxin, CD30 ligand, CD40 ligand, CD27 ligand, and TNF-related 
apoptosis-inducing ligand.  FasL has its N-terminus in the cytoplasm while its C terminus 
extends into the extracellular space.  This extracellular region consists of 150 amino acids 
that is well conserved among the TNF family members.  The sequence and length of the 
cytoplasmic regions are significantly varied.  Soluble TNF is produced by proteolysis of 
membrane associated TNF mediated by a metalloproteinase (Gearing 1994).  Tanaka and 
coworkers (1996) found that membrane associated FasL goes through a similar 
proteolysis to become soluble.  The soluble form of human FasL, but not murine FasL, is 
functional.   FasL exists as a tertiary structure consisting of B-pleated sheets swirled in 
concentric circles similar to TNF (Jones 1989). 
 
The cell surface molecule Fas (also known as APO1 or CD95) is a member of the tumor 
necrosis factor (TNF) receptor family and a type I membrane protein.  Members of the 
TNF receptor family include two TNF receptors (TNF1, TNF2) lymphotoxin-B receptor, 
NGF receptor, CD40, CD27, CD30 (Nagata 1995), death receptor –3/Ws1 (Chinnaiyan 
1996), human herpes virus early mediator (Montgomery 1996), and chicken cytopathic 
avian leucosis-sarcoma virus receptor (Brojatch 1996).   Two to six repeats of a well-
conserved cyteine-rich subdomain are found in the extracellular region of all the TNF 
receptor family members while the cytoplasmic regions have little similarity (Nagata 
1997).  
 
Both TNF1 and TNF2 receptors can transduce the apoptosis signal, although TNF1 is 
thought to do more (Vandenabeele 1995).  Activation and costimulatory signals occur 
due to other receptors in this family, namely CD40 and CD30.  Similarities between 
TNF1 and Fas have brought some to speculate that this area is responsible for apoptosis 
(death) signal transduction.  This was verified in 1993 by two different research groups 
Itoh and Nagata, and Tartaglia and coworkers.  
   11
The first signal develops from ligation of Fas by FasL inducing conformational changes 
to the Fas receptor (Banner 1993).  Recruitment and binding of caspase-8 to specific 
death domains in the Fas/FasL coupling can cause activation of additional  protease 
domains.  Cysteine proteases in the family of interleukin-1β converting enzymes (ICE) 
are activated by proteolytic cleavage from precursors during the ligation of Fas by FasL 
and induce some of the morphological changes seen in the cell.  Homologues of ICE 
were identified and found to cause apoptosis also if expressed in high amounts (Alnemri 
1996).  These were determined to be cysteine proteases that are called caspases (cysteine 
aspases).  Inhibitors of caspase-1 and -3 have been found to block Fas- and TNF- induced 
apoptosis suggesting that both are intimately involved in the process of apoptosis (Enari 
1995, Enari 1996, Los 1995, Tewari 1995,).  Increases in ceramide are also seen during 
fas mediated apoptosis.  Ceramide itself can cause apoptosis.  (Speigel 1996).  Activation 
of ceramide likely occurs downstream of the ICE cascade, since ceramide is not found 
after ICE inhibitors are used (Gamen 1996).   
 
Fas is expressed throughout the human body predominately in the thymus including 
lymphocytes, liver, heart, and kidney.  Ligation of Fas induces apoptosis within hours.  
Expression of Fas and FasL in human airway epithelium, FasL in murine airway 
epithelium and in murine Clara cells is believed to modulate inflammation within the 
lung (Hamman 1998, Gochuico 1998).  The close contact between inflammatory cells 
and respiratory epithelium allows for interactions and modulation of inflammation.  Mice 
deficient in FasL exhibit prominent inflammatory reactions in the submucosa and 
peribronchial regions of the upper and lower airways (Gochuico 1998).  Induction of 
excessive airway inflammation by lack of modulating surface proteins (Fas and FasL) in 
mice or the failure to resolve antigen driven immune responses in human atopic 
asthmatics may be directly related to dysfunctional Fas/FasL pathways.  Abnormalities in 
Fas and/or FasL expression, and therefore apoptotic pathways, in the COPD horse may 
be one reason that affected horses are not able to develop tolerance to common barn 
allergens. 
 
   12
C. Immune Responses in Allergic Airway Diseases: COPD and Asthma  
 
Chronic obstructive pulmonary disease (COPD) is an immune mediated allergic syndrome with a 
worldwide distribution that affects mature horses. The disease has been known by many similar 
names such as heaves, recurrent airway obstruction (Derkson 1985), chronic bronchiolitis, small 
airway disease and chronic bronchitis. The distribution of animals affected with COPD is 
predominately in the Northern Hemisphere where horses are routinely housed indoors for a 
portion of the year.  Reports of the incidence of COPD has ranged from 12-54% (Larson 1985, 
Bracker 1991), but in the later report, the diagnostic criteria used could have included other 
inflammatory conditions of the equine lung.  The syndrome has been defined as “a process 
characterized by chronic bronchiolitis… that may lead to the development of airway 
obstruction”.  The degree of obstruction may vary with the stage of the disease and is reversible 
either by medication or change of environment.   Just stabling susceptible horses can exacerbate 
acute episodes of COPD.  Hypersensitivity to common molds Microsporum faeni and 
Aspergillus fumigatus have been incriminated (McGorum 1993) as possible causes along with 3-
Methylindole (Gerber 1973), previous infection with Equine Influenza virus (Thorsen 1983) and 
genetics (Marti 1991).   
 
Hallmark signs of COPD include acute to chronic coughing, increased respiratory effort and rate, 
tracheal rattle, wheezes, crackles and exercise intolerance.  Cytologic evaluation of tracheal 
aspirates from COPD affected horses with clinical disease show a higher proportion of well 
preserved segmented neutrophils than normal, non-affected horses (Rush-Moore 1995).  
Bronchoalveolar lavage fluid (BALF) obtained from asymptomatic horses contained mostly 
CD8+ T cells with lower proportions of CD4+ T cells and higher proportion of B cells.  After 
natural challenge, recruitment of CD4+ T cells into the tracheobronchial tree predominates and 
decreases the CD4+/CD8+ ratio (McGorum 1993b).  This is similar to findings in atopic 
asthmatics where there is a strong pulmonary recruitment of CD4+ T cells.  
 
Human asthma is also characterized by episodic coughing, wheezing, chest tightness, or a 
combination of these signs (McFaddon 1992).  Exascerbation of asthma can be provoked by 
inducers like allergens, viral infections and occupational agents which serve to enhance any   13
underlying inflammation.  Additionally, exercise, irritants, emotions, and aspirin can promote 
bronchospasm (Brusse 1998).  Bronchoalveolar lavage of asthmatic patients six hours after local 
end-bronchial single allergen challenge documented a decrease in overall T cell percentages and 
an increase in eosinophil percentages although absolute numbers showed a large standard error.  
These T cells recovered by BAL expressed a significant decrease in expression of adhesion 
molecules suggesting that there is a selective retention of T cells within the airway mucosa.  No 
differences from saline challenge were seen in macrophage and neutrophil numbers (Gratziou 
1996).  Bronchial biopsies performed 6 hours after inhalation challenge have revealed an 
increased peribronchial recruitment of CD4
+ T lymphocytes (Montefort 1994). Yet another study 
looking at very early (10-15 minute) changes after local single allergen challenge reflecting an 
early allergic response, detected a marked decrease in CD4
+ T cells with moderate decreases in 
CD8
+ T cells.  No change in the eosinophil numbers were detected (Gratziou 1992).  Borgonovo 
and coworkers (1997) looked at allergen specific, peripheral CD4
+ T cell proliferation 10 
minutes and 24 hours after inhalation allergen challenge.  Allergen specific T cell clones were 
observed to diminish peripherally and expand in the lower respiratory tract.  It appears that very 
early after allergen challenge there is an initial decrease in all T cells, but the late phase response 
is characterized by increased peribronchial CD4
+ cells.  These studies suggest a role for T 
lymphocytes in allergen-induced inflammatory responses in the lung and that antigen specific T 
cell recruitment in asthma may contribute to the maintenance of a pathologic response.   
 
Similarities between human atopic asthmatics and equine COPD have been recognized.  
Human asthmatics possess the same pulmonary recruitment of CD4
+ T lymphocytes in 
bronchoalveolar lavage fluid as COPD affected horses (Spinozzi 1998, Robinson 1993, 
McGorum 1993).  Specific T helper 2 (Th2) subset of T lymphocytes accumulate within 
the peribronchial tissue of the lungs of asthmatics (Ricci 1994).  These cells are IL-4 
positive, interferon gamma negative (IFN-γ 
–) CD4+ T lymphocytes that regulate IgE 
production. T cell derived IL-4 regulates IgE production and helps T helper precursor 
cells differentiate into Th2 cells.  IFN-γ is one of many inhibitory signals for 
differentiation into Th2 cells. IgE production is also elevated in not only asymptomatic 
COPD horses, but in symptomatic animals (Halliwell 1993).  This is consistent with the   14
shift from more CD8
+ T cells predominating in normal horses, to an increase in the 
proportion of CD4
+ T cells in COPD affected horses.  
  
Th2 derived IL-4  and IL-5 have many important physiologic mechanisms that promote 
bronchial hyper-reactivity.  IL-4 promotes mast cell proliferation, anti-immunoglobulin 
activated B cell proliferation along with T cell proliferation while IL-5 promotes B cell 
maturation into plasma cells and eosinophil maturation and activation.  In bronchial 
biopsies and BAL fluid from normal and asthmatic patients, increased IL-4 and IL-5 
mRNA was observed (Humbert 1996, Robinson 1993).  Elevated levels have also been 
observed in BAL fluid and peripheral blood from asthmatic patients (Walker 1992, Del 
Prete 1993, Robinson 1992).  Soluble IL-4 receptor administered to a murine asthma 
model significantly reduced the late phase inflammatory response of airway eosinophil 
infiltration, VCAM-1 expression, and mucus secretion (Henderson 2000).  Additionally, 
administration of interleukin 12 (IL-12) and 18 (IL-18) before antigen challenge has been 
shown to inhibit airway hyper-responsiveness, bronchial inflammation, Th2 cytokine 
expression, serum IgE levels, and eosinophilia in mice (Hofstra 1998, Gavett 1995, 
Keane-Myers 1998).  The use of IL-12 and –18 in inhibiting airway hyper-responsiveness 
suggests that it may in part be due to over stimulation of a Th2 response since both of 
these interleukins promote a Th1 response.  Likewise, the use of soluble IL-4 receptors 
for controlling asthma symptoms distinguishes the Th2 response as well.   Although 
specific subsets of CD4
+ T lymphocytes have not been determined in COPD horses, the 
possibility that they exist is good.  The role of T cells, specifically Th2 cells, in the 
immunopathogenesis of asthma and COPD needs further exploration.  
 
Likewise, the role of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) have been 
found to have important roles in mediating allergic pulmonary inflammation and airway 
hyper-responsiveness (Mark 2000).  Efficient T cell activation requires antigen specific 
engagement of the TCR plus costimulatory molecules CD28 and cytotoxic T lymphocyte 
antigen – four (CTLA-4).  These costimulatory molecules are predominately expressed 
on T cells and bind their receptors B7-1 or B7-2 on the APC (Green 2000).  Interruption   15
of this pathway has been documented to produce anergy in T cells and thus block 
activation (Harding 1992, Lenschow 1992).  
 
 This activation pathway is also thought to play a role in T helper cell differentiation, 
although results have not been able to definitively determine whether B7-1 or B7-2 
preferentially promote a Th1 or a Th2 response.  In a study of in-vitro stimulated memory 
phenotype (CD45RA+) CD4
+ T cells, B7-2 induced an increase in IL-4 while B7-1 did 
not, thereby promoting a more Th2 phenotype  (Freeman 1995).  Other studies looking at 
diseases that are characterized as more of a Th1 disease (experimental allergic 
encephalitis, autoimmune diabetes) (Kuchroo 1995, Racke 1995, Lenschow 1995) have 
found conflicting results when using anti-B7-1 antibiodies, suggesting that there is more 
to discover before the exact role of these costimulatory molecules in Th1 and Th2 
diseases is fully understood.      
 
 
D. Corticosteroids and Attenuation of the Immune Response 
 
Resolution of clinical signs of COPD can occur with environmental changes or 
immunomodulatory therapies like corticosteroids.  Glucocorticoids like dexamethasone 
are a potent inhibitor of the arachidonic acid pathway thereby inhibiting the release of 
eicosanoids including interleukins, prostaglandins and several growth factors. 
Glucocorticoids readily cross the plasma membrane of cells.  Induction of apoptosis in 
thymocytes and lymphocytes involves the binding of the glucocorticoid receptor with the 
steroid.  Induction of lipomodulin by steroid receptor binding inhibits phospholipase A2 
(Cohn 1991).  Phospholipase A2 is able to convert cell membrane phospholipid into 
arachadonic acid and thereby promote inflammation. The absence of, deficiency of, or 
malfunction of this resceptor can abolish glucocorticoid induced apotosis (Harmon 1981, 
Rosenau 1972, Sibley 1974, Gehring 1974).   
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The mechanism that glucocorticoids like dexamethasone use to induce apoptosis has been 
investigated since the early 1980’s.  Glucocorticoid induced apoptosis was shown to 
require protein synthesis when actinomycin and cyclohexamide, RNA and protein 
synthesis blockers respectively, prevented steroid induced apoptosis in thymocytes 
(Wyllie 1984, Cohen 1984). Dexamethasone induced apoptosis is dependent on 
transcriptional regulation of specific cell death genes (Dieken 1992).  Thirteen genes 
expressed specifically in apoptotic immune cells have been characterized (Harringan 
1989, Baughman 1992); the majority show an increase in mRNA shortly (30 minutes to 1 
hour) after dexamethasone exposure.  Of these 13 genes, 2 have been found to repress 
apoptosis while 11 have been found to induce it (Baughman 1992).   
 
Many researchers have investigated the induction of apoptosis by glucocorticoids and 
have battled with the complexity of it. Recently, a more complete understanding of 
dexamethasone induced lymphocyte apoptosis has been identified.  Dexamethasone 
rapidly increases the generation of ceramide through a series of steps involving 
phosphatidylinositol-specific phospholipase C and acidic sphingomyelinase.  This leads 
to caspase activation and eventual apoptosis of the cell (Cifone 1999).  Interestingly, 
tumor necrosis factor-alpha and Fas induce rapid ceramide generation while promoting 
an apoptotic response.      
 
Clinically, dexamethasone has been found to inhibit constitutive MHC class II expression 
on lymphocytes and IFN -γ inducible MHC class II expression on airway epithelial cells 
(Schweibert 1995).  MHC class II cell surface molecules are expressed on all equine 
circulating T lymphocytes (Lunn 1993) and predominately on activated T lymphocytes in 
humans (Miyawaki 1992).  Equine MHC class II cell surface molecules could not only 
differentiate memory from naïve T lymphocytes, but also be used to assess treatment 
efficacy.  Induction of leukocyte apoptosis and phenotypic changes in pulmonary T cells 
by dexamethasone may therefore be responsible for resolution of the inflammatory 
response.  Additionally, preferential apoptosis of human eosinophils with inhibition of 
neutrophil apoptosis when co-cultured has been identified (Meagher 1996).  Dendritic 
cells when exposed to dexamethasone, do not undergo apoptosis, but have a decreased   17
 
 
 
 
antigen presenting capacity and therefore reduced ability to promote T cell proliferation 
(Matasic 1999).  This illustrates the complex nature of dexamethasone-induced resolution 
of pulmonary inflammation.   
 
Figure 3: Sequential signaling events in dexamethasone induced apoptosis 
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E. Equine COPD and Human Asthma: 
 
The association between asthma, allergy and the immune system of affected individuals 
is not well understood.  Asthmatic individuals display continued amplification of 
inflammatory cytokines from activated T helper cells.  Research efforts currently are 
evaluating the role that programmed cell death or apoptosis plays in termination of the 
pulmonary inflammatory response.  Additionally, why some individuals develop asthma 
while others do not may in fact be a direct result of failure in immune modulation of the 
inflammatory reaction incurred by these conditions. 
 
Good animal models of human asthma have not been developed because spontaneous 
attacks of true asthma-like symptoms appear to be rare in animal species other than 
humans.  Equine COPD represents an exception to this statement, and it is the only 
known naturally occurring disease in animals to fulfill the 1962 criteria of the American 
Thoracic Society definition of human asthma (Snapper 1986).  Equine heaves occurs in 
response to exposure to specific allergens and resolves spontaneously when allergen 
exposure ceases (Rush, 1998).  Human asthmatics and horses with COPD both 
experience bronchoconstriction, hypersecretion, and restricted airflow as clinical signs of 
disease.  Activated T lymphocyte percentages from human asthmatic and equine COPD 
bronchoalveolar lavage (BAL) fluid increases with exposure to allergens (Owen-Shaub 
1992, Spinnozi 1996, McGorum 1993).  Furthermore, human asthmatics and COPD 
affected horses possess the same pulmonary recruitment of CD4
+ T lymphocytes in BAL 
fluid (McGorum 1993, Spinnozi 1998).  These findings suggest that the cellular etiology 
of disease may be similar for both humans and horses. 
 
Human atopic asthmatics show defective expression of Fas mRNA and Fas on pulmonary 
T lymphocytes (Spinnozzi 1998).  T cells from asthmatics exposed to anti-Fas 
monoclonal antibodies (stimulating Fas/FasL activation) fail to die whereas over 50% of 
exposed T cells from normal humans undergo apoptosis.  Continued activation is not due 
to a genetic deficiency in Fas expression on circulating T cells and lack of activation.  
Rather, asthmatic’s peripheral blood T cells have greater surface expression of activation   19
markers CD25, HLA-DR, and CD45RO.  This increase in activation marker expression is 
dependent on interleukins secreted by activated T cells and is reflective of activated 
memory cells.  Flow cytometric analysis of asthmatics’ pulmonary T lymphocytes reveals 
lack of Fas expression, whereas in the same patients, the percentage of peripheral T cells 
expressing Fas is similar to normal controls.  The defective expression is therefore 
restricted to pulmonary T cells.  COPD affected horses possess the same pulmonary 
cellular infiltrate of CD4
+ T lymphocytes as symptomatic atopic asthmatics.  Therefore, 
apoptosis contributes to resolution of antigen induced airway inflammation in humans 
and mice and may be one mechanism by which lymphocytes can be programmed to 
tolerate nonpathogenic antigens.  
 
The results of current research suggests that apoptosis plays a significant regulatory role 
in humoral and cellular immunity.  For example, the response of activated B and T 
lymphocytes has been shown to be down regulated by the process of apoptosis 
(Nakayama 1995, Zhou 1998).  Mice, in which lymphocyte apoptotic signaling has been 
incapacitated by mutation, develop autoimmune disease within the first year of life 
(Hagimoto 1997).  Apoptosis also contributes to resolution of antigen induced airway 
inflammation in humans and mice (Hamman 1998, Goichico 1998). These findings 
suggest that apoptosis plays a role in allowing animals to develop tolerance to 
nonpathogenic antigens in their environment.  
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Chapter 2: Adaptation of Three Methods of Measuring 
Bronchoalveolar Lymphocyte Apoptosis in COPD and Normal Horses 
 
Studies in humans and mice suggest that lymphocyte apoptosis serves to regulate 
pulmonary inflammation.  The role of apoptosis in equine chronic obstructive pulmonary 
disease (COPD), a disease clinically similar to human asthma, has not been determined 
due to lack of applicable methods.  Many techniques are available to detect apoptosis.  
Depending on what tissue or cell worked with, user familiarity with the techniques, and 
stage of apoptosis wished to be identified, can govern which techniques are employed.  
Currently, it is advised to use more than one method to identify apoptosis due to the 
inherent strengths and weaknesses of every technique.  In this study, we chose three 
staining techniques, Vindelov’s propidium iodide with Triton-X (PI/Triton-X), 7-
aminoactinomycin D (7-AAD), and Annexin V with propidium iodide (Annexin/PI), that 
have already shown adaptability to other species including humans, mice, birds, and fish.  
These methods are user friendly, uncomplicated and readily adaptable to equine 
bronchoalveolar lymphocytes.   
 
1). The first goal of this study was to adapt three different apoptotic detection methods, 
Annexin-V/Propidium Iodide, 7-aminoactinomycin-D, and Propidium Iodide with Triton-
X, in equine bronchoalveolar cells. 
 
2. The second goal was to compare and evaluate apoptotic staining relationships in all 
three methods.  21
Materials and Methods: 
Animals:   
Nine mixed breed horses ranging in age from 7-20 years (3 mares and 6 geldings) were used in 
the study.  Five of the horses were affected with COPD and 4 were used as normal controls.  
Normal horses were chosen from the university herd and did not have a history of COPD.  
COPD horses at the time of donation to the university herd had a history of COPD so a complete 
respiratory evaluation including transtracheal wash cytology and culture, complete blood count, 
and thoracic radiographs were performed to confirm the diagnosis.  All animals were maintained 
on pasture for at least 2 months prior to the beginning of the study.  Each horse was dewormed 
and vaccinated against influenza and rhinopneumonitis two weeks prior to the first sample 
collection. 
 
Housing and Treatment: 
Each horse was sampled for baseline values while still on pasture and in clinical remission.  Four 
days later, all horses were brought into stalls, bedded on straw and exposed to moldy hay. Stalls 
were cleaned once per day and each horse had ad libitum access to fresh water.  All horses were 
maintained in this environment for four days, and then sampled again.   
 
Bronchoalveolar Lavage Sample Collection:  
Horses were restrained with a twitch and sedated by intravenous administration of acepromazine
1 
(0.02 mg/kg), butorphenol tartate
2  (0.01 mg/kg) and xylazine hydrochloride
3 (0.05 mg/kg). 
Samples were obtained using a BAL tube
4 inserted into either the left or right main stem bronchi. 
The BAL tube was wedged into a caudal lobe and three-100 ml aliquots of phosphate buffered 
saline were infused and aspirated.  Total volume of recovered saline and total cell numbers were 
recorded.  
 
 
 
                                                 
1 Promace Fort Dodge, Fort Dodge, IA 
2 Torbugesic Fort Dodge, Fort Dodge, IA 
3 VedCo, St. Joseph, MO 
4 Bivona Gary, IN   22
Murine Thymocyte Collection and Processing: 
Thymus’s were removed from mice after CO2 asphyxiation and washed twice in RPMI Media 
1640.  Thymocytes were separated through a 60 gauge wire screen and washed again in RPMI 
complete media
5 (with 10% fetal calf serum).  Cells were spun down at 600 x g for 6 minutes, 
reconstituted in 10 ml complete RPMI media 1640 and counted.  Cells were then brought up to a 
final concentration of 2 x 10
6.   Thymocytes were incubated at either 4°C, 37°C, or 37°C with 4 
µg/ml dexamethasone
6 added for 24 hours.  Dexamethasone is known to induce apoptosis in 
murine thymocytes (Willie 1980, Migliorati 1992) and human peripheral blood lymphocytes 
(Dieken 1992, Migita 1997).  Cells were then washed and prepared for staining with the 
apoptotic probes.  
 
Quantifying Apoptosis in BAL and Lymphocytes:  
Cells were washed twice in Ca
++, Mg
++ free phosphate buffered saline
7 (CMF-PBS), counted and 
resuspended to a final concentration of 2 x 10
6 cells/ml.  Aliquots of cells (200,000 cells) were 
cultured in complete RPMI media with 10% fetal calf serum added, for 30 minutes to decrease 
alveolar macrophage numbers, and 12 hours and 24 hours to evaluate apoptosis over time.  Cells 
were then removed from culture, washed in CMF-PBS and immediately stained with three 
apoptotic markers described below.  Cell samples were analyzed on a Coulter Epic XL flow 
cytometer
8.  Forward and side scatter characteristics of a purified population of equine peripheral 
blood lymphocytes, which were treated identically to the BAL samples, were used to define the 
region containing BAL lymphocytes.  A minimum of 5000 events within this region were 
analyzed to determine the percentage of apoptotic cells in each BAL sample. 
 
Method 1: Propidium Iodide (PI): 
DNA fragmentation in individual lymphocytes will be demonstrated by detecting hypodiploid 
DNA content by propidium iodide
9 staining, using a modification of a model described by 
Nicoletti  in 1991.  Briefly, BAL cells were washed 2 times in CMF-PBS with centrifugation at 
400 x g between washes.  After the second wash, 2 x 10
5 BAL cells are aliquoted into 12 x 75 
                                                 
5 Gibco BRL, Grand Island, NY 
6 Phoenix Pharmaceuticals St. Joeseph, MO 
7 Gibco BRL Grand Island, NY 
8 XL software ver 2.0, Hialeah FL 
9 PI; Sigma St. Louis, MO   23
mm polypropylene tubes and 200 µl of PI/Triton-X solution (1% Na Citrate, 0.01% Triton X-
100, 0.1% PI qs to 50 ml diH20), at 100 mg/ml concentration in CMF-PBS, were added to the 
cells. 
 
Method 2: 7-Aminoactinomycin (7-AAD): 
Identification of DNA fragmentation occurring in either intermediate or late apoptosis was  
demonstrated with vital dye 7-AAD
10.   The cells were prepared in the following manner using a 
modification of a model described by Schmid  in 1994.   A 100 µl aliquot containing 2 x 10
5 
cells/100 µl was collected into 12 x 75 mm polypropylene tubes and washed in cold PBS at 400 
x g for 5 minutes.  Cells were incubated with 1.0 µg/100 µl of 7-AAD in PBS on ice in the dark 
for 15 minutes. 
 
Method 3:Annexin V 
Identification of early apoptotic cells via binding of the exposed phospholipid phosphatidylserine 
was demonstrated with Annexin V-FITC
11.  Double color analysis with vital dye PI allowed 
identification of plasma membrane integrity and early apoptotic versus dead cells.  Briefly, 
washed cells were resuspended in 100 µl of kit binding buffer as per the manufacturer’s 
protocol.
12  To each tube, 50 µl of Annexin V-FITC-binding buffer (0.5 µg/ml) and 50 µl PI 
(100µg/ml) was added and incubated in the dark for 15 minutes.  
 
Statistical Evaluation:   
The CORR procedure of the SAS system
13 was used to calculate Spearman partial correlation 
coefficients between each apoptotic staining method in equine BAL cells after partialing out day 
(baseline, after natural challenge) and disease status (COPD or normal). The CORR procedure of 
the SAS system was used to calculate Pearson correlation coefficients between each apoptotic 
staining method in murine thymocytes.  
                                                 
10 Molecular Probes Eugene, OR 
11 Annexin V kit, PharMingen International San Diego, CA 
12 PharMingin International, Annexin V – FITC Technical Data Sheet, Catalog #65874H 
13 Sas System, version 8.01 Sas Institute Inc. Cary, NC 27513   24
Association between percentages of murine thymocytes stained with each method were subjected 
to and tested for significance. Pearson’s correlation coefficients were calculated using the CORR 
procedure of SAS system.   
 
Results: 
Significant correlation was found between all staining procedures done with a homogeneous 
population of murine thymocytes (PI/Triton-X and Annexin/PI r = 0.735, p<0.003; PI/Triton-X 
and 7-AAD r = 0.873, p<0.005; Annexin/PI and 7-AAD r = 0.952, p<0.0003).   Likewise, a 
significant linear relationship was identified between 7-AAD late and Annexin/PI late apoptotic 
staining at time 4 hours (r = 0.69, p < 0.002), time 12 hours (r = 0.53, p < 0.03) and time 24 
hours (r = 0.63, p < 0.007) post BAL (Figure1).  Annexin/PI late staining and 7-AAD early 
staining were significantly correlated at times 4 (r = 0.59, p < 0.01) and 24 (r = 0.76, p < 0.0004), 
but not at time 12 hours post BAL (Figure 2).  Annexin/PI early staining and 7-AAD late 
staining were strongly correlated at time 12 (r = 0.63, p < 0.007), but not at times 4 and 24 hours 
post BAL (Figure 3).  No significant staining relationships were identified between Annexin/PI 
early and 7-AAD early, PI/Triton-X and Annexin/PI  and PI/Triton-X and 7-AAD total apoptotic 
staining.  No differences in lymphocyte staining were identified by all three methods in COPD 
and normal horses at all time points.   25
 
Figure 1: Scatter plots illustrating significant linear relationships at all time points between 7-
AAD late (aadl) and Annexin/PI late (annl) apoptotic staining percentages in equine BAL 
lymphocytes.  Solid circles represent COPD affected horses and open circles are control horses.  
Day 1 represents baseline values with all horses clinically normal.  Day 8 represents apoptotic 
staining after natural challenge with moldy hay for 96 hours.  26
 
Figure 2:  Scatter plots illustrating significant linear relationships between 7-AAD early (aade) 
and Annexin/PI late (annl) apoptotic staining percentages for time 4 and 24 hours.  More 
variation and a lower correlation is seen at time 12 hours.  Solid circles represent COPD affected 
horses and open circles are control horses.  Day 1 represents baseline values with all horses 
clinically normal.  Day 8 represents apoptotic staining after natural challenge with moldy hay for 
96 hours.   27
 
Figure 3: Scatter plots illustrating significant linear relationships between 7-AAD late (aadl) and 
Annexin/PI early (anne) apoptotic staining percentages for time 12 and 24 hours.  Solid circles 
represent COPD affected horses and open circles are control horses.  Day 1 represents baseline 
values with all horses clinically normal.  Day 8 represents apoptotic staining after natural 
challenge with moldy hay for 96 hours.  28
Table 1:  Spearman’s correlation coefficient for each apoptotic staining relationship in equine BAL lymphocytes 
 
                                                                                                 Time in Culture 
 
        Apoptotic Stain                              4                            12                         24 
 
Annexin early x 7-AAD early                0.4                            0.23                       -0.15 
 
Annexin early x  7-AAD late                 0.38                          0.63*                       0.48* 
 
Annexin late x 7-AAD late                 0.69*                        0.53*                       0.63* 
 
Annexin late x 7-AAD early               0.59*                        0.39*                       0.76* 
 
PI x Annexin/PI total staining           -0.12                          0.23                        0.39 
 
PI x 7-AAD total staining                  -0.11                          0.21                        0.39 
 
 
  
An * denotes significant (p < 0.05) linear relationship between the two stains.  Values are the result of 18 observations per 
stain.  29
Table 2: Individual staining medians and range of each apoptotic probe for each time point in equine BAL lymphocytes
a . 
 
                                                                             Time in Culture 
   Apoptotic Stain                         4                                     12                                    24 
 
  
 
a Each value is the median of nine horses with COPD and control horses together  
Annexin early              8.2 (0.64 – 40.6) 
Annexin late                4.4 (1.48 – 10.9) 
7-AAD early               3.1 (0.30 – 10.7) 
7-AAD late                 6.9 (0.16 – 14.6) 
Propidium Iodide        2.7 (1.10 – 38.6) 
8.6 (0.56 – 36.2) 
4.5 (0.98 – 16.5) 
3.5 (0.40 – 57.0) 
7.3 (0.63 – 20.4) 
3.3 (1.10 – 24.3) 
25.2 (1.18 – 53.6) 
15.7 (2.34 – 37.3) 
 9.7 (1.47 – 36.5) 
16.9 (2.09 – 33.7) 
11.6 (4.48 – 38.6)   30
Discussion 
The first method that was examined was propidium iodine (PI) in a buffer containing 
0.01 percentage Triton X.  PI is a vital stain that intercalates into DNA, fluoresces in the 
orange range of the spectrum, and can be detected by flow cytometry using a 562-588 nm 
band pass filter.  Most commonly, this stain is used to detect live verses dead cells; the 
intact cell membrane of live cells excludes the stain, while the cell membrane of dead 
cells fails to act as an effective barrier to PI.  Since loss of cell membrane integrity occurs 
only in necrotic and late apoptotic cells, PI staining alone is not considered a sensitive 
marker of apoptosis. The use of PI in combination with Triton X permits the stain access 
to DNA at a much earlier time in the apoptotic process. Triton X, acting as a detergent, 
eliminates the membrane from all of the cells in the population. The size of the exposed 
DNA may then be determined based on the amount of fluorescence that the particle emits 
as it passes though a flow cytometer. The larger the DNA fragment, the greater amount of 
PI contained within that fragment, and the greater the fluorescence. DNA from cells that 
are alive produces the greatest amount of fluorescence, while DNA from apoptotic cells 
have a characteristic hypodiploid subGo peak, and DNA fragments from necrotic cells 
give off very little fluorescence (Refer to appendix B - E).   
 
One significant advantage of this method is that it is very simple; addition of PI/Triton-X 
to the cell population is a one step process, limiting time between collection and staining, 
and minimizing the effects of sample processing. Cell populations stained with PI/Triton-
X can also be stored (4°C in the dark) for at least 24 hours without affecting the results.  
The disadvantage to this method is that removal of the cell membrane eliminates the 
possibility of using forward and side scatter characteristics to differentiate between cell 
populations within a sample.  As shown this study, the results obtained using the 
PI/Triton-X method only correlate well with methods when the cell population being 
evaluated is homogeneous.  In heterogeneous populations, like those obtained by BAL, 
the percent of apoptosis present in the whole population does not consistently correlate 
well with results obtained using methods that permit evaluation of specific populations, 
like lymphocytes, within the group.    31
7-amino-actinomycin (7-AAD), a nucleic acid binding dye, was the second method 
adapted to measure apoptosis in equine BAL lymphocytes. Like PI, 7-AAD is a vital, 
fluorescent dye that binds to DNA.  7-AAD fluoresces in the far-red range of the 
spectrum and can be detected using a 650 nm long-pass filter. Unlike PI, 7-AAD is able 
to traverse an intact plasma membrane and intercalate in between cytosine and guanine 
bases in DNA. It is thought that 7-AAD crosses the plasma membrane of apoptotic cells 
and achieve higher intercellular concentrations than PI (Schmid 1994), but the exact 
mechanism of membrane transfer of 7-AAD is unknown.  Using lower concentrations of 
7-AAD (1 µg/ml concentration), as was done in this experiment, minimizes staining and 
background florescence of live cells.   For the purpose of this study, cells with dull 
fluorescence were considered alive, intermediate fluorescent cells were considered early 
to mid apoptotic (aade), and bright fluorescent cells were considered late apoptotic (aadl).  
This categorization has previously been published by Schmidt and coworkes (1994).   
 
7-AAD is a sensitive indicator of DNA fragmentation associated with apoptosis that does 
not require the removal of the cell membrane to facilitate DNA staining.  Since the cell 
membrane remains intact, forward and side characteristics can be used to differentiate 
between cell population within a heterogeneous sample.  Double staining methods may 
also be applied by counterstaining with markers labeled with fluorescent dyes that emit 
light in a wavelength that differs from 7-AAD.  7-AAD staining is also rapid and requires 
limited manipulation of the cell population. The disadvantage to this method is that cells 
cannot be stored overnight and analyzed the following day.  Methods have been reported 
for fixing cells in paraformaldehyde to permit analysis later.  Results of preliminary 
experiments performed in this lab, however indicate that twelve hour fixation of cells 
stained with 7-AAD significantly increases the amount of apoptosis observed in the 
samples (data not shown).   
 
Annexin-V with PI was the third method that was utilized for this project. Annexin-V is a 
calcium dependent binding dye used to identify phospholipid changes in the cell 
membrane.  For the purpose of this study, Annexin V was labeled with fluorescein 
isothiocyanate (FITC), which fluoresces, in the blue-green range of the spectrum.   32
Staining with only Annexin-V identifies early apoptotic cells with their phosphatylserine 
molecules exposed. Double staining with PI permits identification of cells that are later in 
the apoptotic process, since substantial changes in cell membrane integrity must occur 
before PI can gain access to the DNA. By applying both stains, live cells have minimal 
fluorescence, early apoptotic cells (anne) stain with Annexin V FITC only, late apoptotic 
cells (annl) stain both with the Annexin V FITC and PI, and necrotic cells stain with PI 
only.  In this experiment, Annexin/PI total (anntot) was considered the sum of values 
measured for Annexin early and Annexin late in each sample. For the purpose of this 
study, the total number of cells undergoing apoptosis was used for comparison with the 
PI/Triton-X and 7-AAD results, since staining with Annexin/PI was the only method that 
could distinguish cell changes associated with stages of apoptosis. 
 
While staining with Annexin/PI is not complex, it does require more time and preparation 
that the first two methods described.  If Annexin-V FITC staining is used alone, it may be 
possible (though not recommended) for cells to be fixed and analyzed the next day.  In 
the absence of PI staining, early and late apoptosis cannot be detected, but the total 
number of cells undergoing apoptosis can be identified.  If double staining with PI is 
performed, cells cannot be fixed, since paraformaldehyde fixation will result in all of the 
cells taking up PI stain.  If the cells are not fixed, the samples must be analyzed 
immediately to obtain accurate data.  
 
The results obtained when analyzing murine thymocytes demonstrate that all three 
methods correlate well when a homogeneous population of cells is being analyzed.  This 
finding is in agreement with previously published apoptotic results in murine thymocytes 
(Donner 1999).  Likewise, studies using homogeneous populations of peripheral 
lymphocytes in humans (Lecoeur 1997), fish (Gogal  2000), and birds (Gogal, submitted 
for publication 2001) have identified significant staining relationships between 7-AAD 
and Annexin-V/PI.  In contrast, results do not correlate well when evaluating a 
heterogeneous cell populations, like equine BAL lymphocytes. Since morphologic 
characteristics of the cell membrane are lost when using the PI\Triton-X method, specific 
cells population within the BAL samples can not be analyzed individually.  In contrast,   33
both 7-AAD and Annexin V/PI are methods which preserve the cell membrane characters 
and permit gating on lymphocytes with the BAL population, based on predetermined 
forward and side scatter characteristics. It is therefore likely that the percent of 
lymphocytes undergoing apoptosis in BAL samples differs from the percentage of total 
cells within the population that are apoptotic.  Values obtained from all three methods 
may more accurately detect lymphocyte apoptosis if steps were taken to isolate BAL 
lymphocytes from the rest of the cells in BAL samples.  Phagocytosis of apoptotic BAL 
lymphocytes by alveolar macrophages may have erroneously lowered the percentage of 
apoptosis detected by each method and affected correlation values.  However, isolation 
procedures require additional manipulation of the sample, and may alter apoptotic 
percentages also.  Strong correlation values obtained with 7-AAD late and Annexin/PI 
late apoptotic staining for all time points measured suggests that these stains are 
identifying similar apoptotic time points.  More variation in correlation values between 7-
AAD early and Annexin late, and 7-AAD late and Annexin early staining, suggests that 
these stains are likely to have some staining overlap of the apoptotic cycle, but that it 
might not be consistent in a heterogeneous population.  Apoptotic staining with 7-AAD 
has been shown to be altered in the presence of granulocytes and red blood cells (Philpott 
1996) which may have altered correlation values in this study.  Additionally, at different 
time points in culture, a greater proportion of cells may be either early or late apoptotic, 
thereby affecting correlation values when evaluating this type of relationship.  Lastly, the 
involvement of the alveolar macrophage to identify and phagocytose apoptotic cells can 
not be underestimated.  Although culture of BAL cells for 30 minutes reduced alveolar 
macrophage numbers by approximately 30% (data not shown), complete elimination was 
not possible in this present study.   Based on these finding, 7-AAD and AnnexinV/PI 
methods are the most comparable methods for evaluating lymphocyte apoptosis in equine 
BAL lymphocytes, although the PI\Triton-X method is the simplest and most convenient 
of the three tested.  When evaluating apoptosis in a homogeneous population of cells, the 
PI\Triton-X method should be considered.    34
Chapter 3: Comparison of Equine Bronchoalveolar Lavage 
Lymphocyte Apoptosis in Normal and COPD Affected Horses Before 
and After Dexamethasone Administration   
 
An introduction for this section was provided in Chapter 1. 
 
Aims of Study: 
1).  The first goal of this study was to compare bronchoalveolar lavage retrieved 
lymphocyte apoptosis in control and COPD affected horses during remission and after 
natural challenge.   
 
2). The second goal of this study was to compare bronchoalveolar lavage retrieved 
lymphocyte apoptosis in control and COPD affected horses after four days of 
dexamethasone administration.    35
I.  Materials and Methods: 
Animals:   
Nine mixed breed horses ranging in age from 7-20 years (3 mares and 6 geldings) were used in 
the study.  Five of the horses were affected with COPD and 4 were used as normal controls.  
Normal horses were chosen from the university herd and did not have a history of COPD.  
COPD horses at the time of donation to the university herd had a complete respiratory evaluation 
including transtracheal wash cytology and culture, complete blood count, and thoracic 
radiographs to diagnose COPD.  All animals were maintained on pasture for at least 2 months 
prior to the beginning of the study.  Each horse was dewormed with ivermectin
14 (200µg/kg PO) 
and vaccinated against influenza and rhinopneumonitis two weeks prior to the first sample 
collection.   
 
Housing and Treatment: 
Each horse was sampled for baseline values while still on pasture and in clinical remission.  Four 
days later, all horses were brought into stalls, bedded on straw and exposed to moldy hay. Stalls 
were cleaned once per day and each horse had ad libitum access to fresh water.  All horses were 
maintained in this environment for four days, and then sampled again.  Horses were then 
administered dexamethasone sodium phosphate
15 (0.1 mg/kg IV,) for four days, and sampled a 
final time.   
 
Clinical Disease Assessment:  
Horses were deemed to be experiencing an acute exacerbation of COPD if they were exhibiting 
increased respiratory rate, increased respiratory effort, coughing, and/or if auscultable wheezes 
were heard.  None of the COPD horses were experiencing clinical disease at the start of the 
study, but all developed varied degrees of clinical severity by Day 8 (4 days after natural 
challenge with moldy hay).  None of the control horses exhibited any of the above clinical signs. 
 
 
 
                                                 
14 Eqvalan liquid, MSD-Agvet 
15 American Regent Laboratories, Inc. Shirley, NY   36
Pulmonary Function Evaluation:  
Horses were restrained in stocks and methods previously described by Davis in 1998 was used. 
Determination of gas exchange indices that measure respiratory function including physiologic 
shunt fraction (Qs/Qt), alveolar dead space ventilation fraction (Vd/Vt), and alveolar to arterial 
oxygen tension difference (p(A-a)O2)  were performed. Sampling procedures for determination of 
Qs/Qt and Vd/Vt included arterial (carotid artery) and venous (jugular vein) puncture, end-tidal 
CO2 (ETCO2) measured from an 18-gauge needle placed percutaneously (with infiltration of a 
local anesthetic) into the trachea, rectal temperature, and atmospheric barometric pressure. 
Qs/Qt,  Vd/Vt and p(A-a)O2 were calculated using standard formulas (Davis 1998).  
 
Bronchoalveolar Lavage Sample Collection:  
Horses were restrained with a twitch and provided sedation by intravenous administration of 
acepromazine
16 (0.02 mg/kg), butorphenol tartate
17 (0.01 mg/kg) and xylazine hydrochloride
18  
(0.05 mg/kg). Samples were obtained using a BAL tube
19 inserted into either the left or right 
main stem bronchi. The BAL tube was wedged into a caudal lobe and three-100 ml aliquots of 
phosphate buffered saline were infused and aspirated.  Endoscopic evaluation of BAL tube 
placement precluded repeated sampling of one lung more than once in 96 hours.  The cells were 
kept in phosphate buffered saline and on ice until processed.  Cytologic evaluation of a minimum 
of 300 cells was also performed. 
 
Quantifying Apoptosis in BAL and Lymphocytes:  
Cells were washed twice in Ca
++, Mg
++ free phosphate buffered saline
20 (CMF-PBS), counted 
and resuspended to a final concentration of 2 x 10
6 cells/ml.  Aliquots of cells (200,000 cells) 
were cultured in complete RPMI media with 10% fetal calf serum added, for 30 minutes, 12 
hours and 24 hours on each day.  Cells were then removed from culture, washed in CMF-PBS 
and immediately stained with three apoptotic markers described below.   Cell samples were 
analyzed on a Coulter Epic XL flow cytometer
21.  Forward and side scatter characteristics of a 
                                                 
16 Promazine Fort Dodge, Fort Dodge, IA 
17 Torbugesic Fort Dodge, Fort Dodge, IA 
18 VedCo, St. Joseph, MO 
19 Bivona Gary, IN 
20 Gibco BRL Grand Island, NY 
21 XL software ver. 2.0, Hialeah FL   37
purified population of equine peripheral blood lymphocytes, which were treated identically to the 
BAL samples, were used to define the region containing BAL lymphocytes.  A minimum of 
5000 events within this region was analyzed to determine the percentage of apoptotic cells in 
each BAL sample. 
 
Apoptotic Staining Procedures: 
Refer to materials and methods Chapter 2. 
 
Statistical Evaluation: 
To evaluate effects on lymphocyte apoptotic staining, repeated measures analysis of variance 
was performed using the MIXED Procedure of the SAS System
22.  The analysis of variance 
tested for the effects of disease status (COPD, normal), time in culture, day, and their 
interactions.  Tukey’s HSD test was performed when significant differences were detected.   
 
To verify development of clinical disease, pulmonary function values were subjected to repeated 
measures analysis of variance using the MIXED Procedure of the SAS System. The analysis of 
variance tested for the effects of disease status (COPD, normal), day, and their interactions.  
 
                                                 
22 ver. 8.01 SAS Institute Inc. Cary, NC 27513   38
II.  Results: 
 
No significant differences were observed between groups (COPD, control) for percentages of 
apoptotic lymphocytes for all three sampling days with all three apoptotic staining probes.  A 
significant time in culture effect with increased lymphocyte apoptosis identified by all stains at 
time 24 hours post BAL detected (figure 1).  Annexin early (Anne) staining identified a 
significant time by day effect with decreased early apoptosis seen on Day 12 (after 
dexamethasone administration) at time 12 and 24 hours post BAL (figure 2).  Numerical trends 
were observed in the COPD group for less apoptosis on Day 8 (after natural challenge) and 
increases in apoptosis by Day 12 (after dexamethasone administration) more toward initial 
baseline values (table 3). 
 
Before treatment and natural challenge with moldy hay, mean baseline responses +/- standard 
error for control and COPD horses on Day 1 were within the normal reported ranges for 
physiologic shunt fraction (Qs/Qt), alveolar dead space fraction (Vd/Vt), and alveolar to arterial 
oxygen tension difference (p(A-a)O2).  No differences in baseline values were observed between 
normal and COPD horses on Day 1 for Qs/Qt, although significant differences were seen after 
natural challenge on Day 8 and after dexamethasone administration on Day 12.  Significant 
differences were observed on all days for Vd/Vt between normal and COPD horses. 
Additionally, for both groups of horses, significant differences were observed in Vd/Vt between 
baseline values on Day 1 and after natural challenge on Day 8, and from Day 1 and after 
dexamethasone administration on Day 12 (Table 1) substantiating the observed clinical signs of 
airway obstruction in the COPD horses.  COPD horses had significantly elevated p(A-a)O2 values 
above the normal horses for all days although the elevations were above the reported normal 
range for Days 8 and 12 only.  Dexamethasone administration was associated with trends of 
decreasing Qs/Qt values in both groups of horses with similar trends in Vd/Vt values in the 
COPD group.   
 
Bronchoalveolar lavage retrieved macrophage percentages were significantly lower in the COPD 
horses than conrol horses at all days.  COPD horses also had significantly less observed 
macrophages on Days 8 after natural challenge and 12 after dexamethasone administration when   39
compared to baseline values on Day 1.  Lymphocyte percentages retrieved from BAL fluid were 
significantly greater on Day 1 than on Days 8 or 12 for both groups of horses.  Likewise, BAL 
retrieved neutrophil percentages were significantly less on Day 1 than Day 8 for both groups of 
horses (Table 2).  Dexamethasone administration was associated with trends of improvement 
toward normal reported values for BAL cytology in the COPD horses.  40
Figure 1: Geometric means of predominately BAL lymphocyte apoptosis for each stain plotted 
by time in culture
a  
aPlot illustrates significant increases in apoptosis percentages at time 24  (p < 0.001) hours in 
culture versus times 4 or 12 hours regardless of disease status.  Geometric means are calculated 
from the percentages of nine horses including both COPD and controls. 
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Figure 2: Annexin early (Anne) staining time by day effects
a 
 
a Graph illustrates significant differences in apoptotic staining lymphocyte percentages on Day 1 
and Day 8 at time 24 hours culture when compared to time 4 and 12 hours culture.  Day 12 time 
4 hour culture illustrates significant differences from time 12 and 24 hours culture.  All points 
represent 18 observations each from 4 control horses and 5 COPD horses. 
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Table 1: Mean pulmonary function testing responses +/- standard error at baseline (Day 1), after natural challenge (Day 8), and after 
dexamethasone administration (Day 12) for COPD and control horses
a.   
 
Group  Day  Qs/Qt %  Vd/Vt %  p(A-a)O2 mmHg 
Control 
COPD 
Control 
COPD 
Control 
COPD 
1 
1 
8 
8 
12 
12 
4.21 +/- 1.23 
6.30 +/- 1.27 
5.24 +/- 0.53* 
19.41 +/- 5.73* 
1.45 +/- 0.65* 
12.10 +/- 3.85* 
-14.78 +/- 7.48 
-3.10 +/- 5.35 
-5.80 +/- 5.05 
17.44 +/- 8.21 
-5.75 +/- 4.68 
6.48 +/- 7.06 
12.29 +/- 3.22 
23.03 +/- 3.81 
10.86 +/- 3.79 
28.10 +/- 5.18 
8.87 +/- 6.67 
29.23 +/-3.89 
 
aEach value is the mean of 4 control horses or 5 COPD horses. * Qs/Qt values illustrates significant differences between COPD horses 
and normal horses on Days 8 and 12.   Vd/Vt values illustrates significant differences between COPD horses and normal horses on all 
days measured, and for both groups, Day 1 is significantly different than Days 8 and 12.  P(A-a)O2 values are all significantly higher in 
the COPD horse group than the control group for all days measured.  43
Table 2: Mean cytologic responses +/- SE at baseline (Day 1), after natural challenge (Day 8), and after dexamethasone administration 
(Day 12) in COPD and control horses
b. 
 
Group Day Macrophage  % Lymphocyte  % Neutrophil % Eosinophil %  Mast Cell %
Normal  1  45.18 +/-3.20  49.95 +/-3.47  1.22 +/-0.46  0.05 +/-0.03  3.60 +/-1.54 
COPD  1  35.42 +/-4.92  53.18 +/-6.52  6.60 +/-2.96  0.22 +/-0.20  4.22 +/-2.20 
Normal  8  42.88 +/-4.25  40.53 +/-8.08  13.18 +/-8.09  0.20 +/-0.12  3.15 +/-0.93 
COPD  8  26.46 +/-4.48*  35.74 +/-8.02*  35.50 +/-9.33* 0.00 +/- 0.0  2.30 +/-0.34 
Normal  12  57.00 +/-8.22  34.58 +/-8.18  5.38 +/-4.73  0.30 +/-0.18  2.58 +/-0.71 
COPD  12  33.18 +/2.91  41.78 +/-5.58  22.10 +/- 6.60  0.10 +/-0.06  2.92 +/-2.35 
 
bEach value is the mean of 4 control horses or 5 COPD horses.  COPD horses had significantly less BAL macrophages on all days 
compared to control horses and Day 1 macrophage percentages were different than Days 8 and 12 for both groups.  A day effect was 
observed in both groups of horses for BAL lymphocyte percentages with Day 1 significantly different than Days 8 and 12 values.  
Both groups had a significant day effect for BAL neutrophil percentages on Day 1 compared to Day 8.  No significant changes were 
observed in the eosinophil or mast cell percentages.   44
Table 3: Numerical apoptotic cell percentage means for each stain and horse group for all time points in culture
a 
 
Group  Day 1  Day 8  Day 12  Stain 
Control  4.49  6.77  5.05  Aade 
COPD  5.05  3.10  6.63  Aade 
Control 13.16  14.27  5.71  Anne 
COPD 9.34  8.03  4.71  Anne 
Control  12.72  8.80  14.47  Aadl 
COPD  7.23  6.68  7.68  Aadl 
Control 7.69 7.87  5.32 Annl 
COPD 4.83  5.73  3.84 Annl 
Control  2.84  5.85  4.64  PI 
COPD  6.71  9.61  8.16  PI 
 
a Illustrates numerical trends seen in time in culture by day of disease (baseline, after natural challenge, and after dexamethasone 
administration) staining effects for each stain and horse grouping.  Means are the results from 4 control or 5 COPD horses.   45
III. Discussion 
 
Apoptosis is one of the mechanisms that the body uses to terminate an immune response 
once that response is not needed anymore (Nakayama 1995, Zhou 1998).   Alterations in 
physiologic apoptosis of lymphocytes has been shown to contribute to pathologic 
conditions in mice in which lymphocyte apoptotic signaling has been incapacitated by 
mutation (Hagimoto 1997).  Additionally, apoptosis also contributes to resolution of 
antigen induced airway inflammation in humans and mice (Hamman 1998, Goichico 
1998).   
 
The lack of any significant differences between the COPD and control horse groups in 
percentage of apoptotic BAL lymphocytes from baseline to after antigenic challenge and 
after dexamethasone administration may be due, in part, to the small (nine horses) sample 
population.  Additionally, individual horse to horse variation within each group may have 
contributed.  There was a large variation in disease severity of the COPD horses ranging 
from mild clinical signs to severe.   This can be appreciated in the lack of significant 
changes between groups for baseline to natural challenge and after dexamethasone 
administration in both the pulmonary function data (Qs/Qt, Vd/Vt, (p(A-a)O2)) and BAL 
cytologic evaluation.  Although there were changes from day to day within the COPD 
group that were significant, the magnitude of the change when compared to the normal 
horses was not.   
 
The possibility that there are no real differences between COPD and control horse BAL 
lymphocyte apoptosis exists, but this study can not draw that conclusion definitively.  
Additional manipulation of the BAL cells to purify the population or inactivation of 
phagocytic cells may be required to further investigate this phenomenon.  In vitro 
inactivation of macrophages has recently been reported (Callahan 2000).  Additionally, 
pre-incubation of lymphocytes with Annexin-V, has been shown to retard macrophage 
phagocytosis (Krahling 1999).  This may be a viable alternative to purification of the 
BAL cell population, as purification (and added manipulation of the cells) may in itself, 
alter the percentage of apoptotic cells thereby skewing the results.     46
 
Dexamethasone has been shown to induce apoptosis in leukocytes (Donner1999, Schmid 
1994), but these results are from in-vitro studies.  This study dealt with dexamethasone in 
an in-vivo model and our ability to quantitate apoptosis in BAL cells.  Lymphocytes 
exposed to dexamethasone in-vitro can exhibit early apoptosis as early as 1 – 2 hours 
after exposure (Donner 1999, Schmid 1994), while in this present study, we did not 
perform BAL until 96 hours after the first exposure.  Therefore, the possibility that we 
may have missed a major apoptotic event may exist.  Additionally, activated lymphocytes 
have been shown to be resistant to Fas-mediated apoptosis (Inaba 1999) and rescued from 
apoptosis in the tissue of origin from where they first encountered the antigen (Bode 
1997).  It is therefore possible that BAL lymphocytes may be predetermined to enter the 
bronchial or alveolar lumen and die.  Peribronchial lymphocytes that infiltrate the walls 
of the bronchi during inflammatory states may therefore be the cells that need to be 
investigated more thoroughly.  More studies involving more horses are needed to identify 
this. 
 
This study did identify increased lymphocyte apoptosis as measured by all stains at time 
24 hours post BAL.  This is in agreement with previously published studies with the 
kinetics of lymphocyte cell death in culture (Donner 1999, Schmid 1994).  Early 
lymphocyte apoptosis as measured by Annexin-V
+/PI
- staining had a significant Day by 
Time effect magnified by Day 12.  Annexin/PI staining is the earliest method of 
determining apoptosis that this study employed.  Therefore, decreased early apoptotic 
staining on Day 12 at times 12 and 24 hours post BAL is indication that a greater 
proportion of cells were dying earlier than on previous days.  This indirectly supports our 
hypothesis that dexamethasone increases lymphocyte apoptosis.   
  
The use of pulmonary function testing in horses is to help determine the degree of gas 
exchange compromise that exists with both upper and lower airway conditions.  Most 
techniques have been verified in the exercised horse with the use of a treadmill.  Davis 
(1998) developed methods to measure physiologic shunt fraction and alveolar dead space 
fractions that can be used in the standing horse.    Friday (2000) further modified these   47
methods for use in the standing horse.   These methods are generally considered more 
sensitive in determining subtle gas exchange inefficiencies as compared to classic 
techniques (Votion 1999).   
 
Pulmonary ventilation in the horse is used to deliver oxygen to the pulmonary venous 
blood resulting in continuous oxygen renewal.  Areas of gas exchange in the lungs 
include the alveoli, alveolar sacs, alveolar ducts and respiratory bronchioles.  The rate at 
which air reaches these areas is termed ‘alveolar ventilation’.  During normal quiet 
breathing, only a small amount of inspired air actually reaches the alveoli; most inspired 
air moves by diffusion into the terminal airways (Guyton 1999).   
 
The air in the larger airways, nasal passage, pharynx and trachea, make up what is termed 
‘dead air space’.   All respiratory passages except the alveoli is termed the ‘anatomic 
dead space’; an area that does not participate in gas exchange.  When alveoli are not 
participating in gas exchange due to inadequate ventilation or hypoperfusion, and are 
included in the measurement of dead space, the resultant term is ‘physiologic dead 
space’.   
 
Important determinates of arterial blood oxygenation is ventilation-perfusion (V/Q) 
matching.  Mild mismatching occurs normally in the standing horse with increased 
perfusion (decreased V/Q) to the ventral lung lobes and increased ventilation (increased 
V/Q) to the dorsal lobes (Amis 1984).   This is also the most important and common gas 
exchange problem in horses with lower airway disease (O’Callaghan 1991). Indices that 
are used to determine any amount of V/Q mismatching are the physiologic shunt fraction 
(Qs/Qt), dead space fraction (Vd/Vt), and the alveolar to arterial gradient (P(A-a)O2).  
Qs/Qt is used to identify areas of oxygen deficits with a V/Q <1 as with extrapulmonary 
shunting and diffusion impairments.  Vd/Vt is used to identify areas of oxygen deficits 
with a V/Q >1.   P(A-a)O2 is another method to determine relative gas exchange efficiency 
and the amount of physiologic shunting of blood away from low V/Q or nonventilated 
areas (McDonell 1996). With P(A-a)O2  elevations above normal, the oxygen diffusion 
barrier is increased.  In clinically affected COPD horses, elevations in the Qs/Qt and P(A-  48
a)O2 have been observed (Nyman 1991, Votion 1999, Littlejohn 1982) likely due to 
increased bronchoconstriction resulting in lower oxygen tensions in some alveoli and/or 
underperfusion of some alveoli. Hypersecretion of mucus and bronchiol plugging could 
contribute also. Increased Vd/Vt has also been observed in COPD horses associated with 
hypercapnea although the reported values are quite varied (0.49% +/- 0.05, -18.2% +/- 
3.1, and 6.1%, mean +/- s.d.) (Davis 1998, Gallivan 1989, Littlejohn 1982).  
Additionally, normal horses have been found to have a wide variation is what is 
considered normal for Qs/Qt and P(A-a)O2  values.  Qs/Qt values range from 0.7% +/- 0.31 
(mean +/- s.d.) to 8.8 +/- 3.9 while P(A-a)O2  has been observed to range from 4-25 mmHg 
(Aguilera – Tejero 1998, Mauderly 1974).   
 
 Significant mean alterations in the physiologic shunt fraction in the COPD horses from baseline 
(Day1) to after natural challenge (Day 8) and after dexamethasone administration when 
compared to normal horses substantiates the observed clinical signs of COPD.  Additionally, 
alveolar dead space fractions and the alveolar to arterial difference are significantly different in 
the COPD horses compared to the normal horses at all days suggesting that the COPD horses had 
possible bronchial remodeling from chronic COPD.  Although the alveolar dead space value is 
elevated from baseline, it is still within reported normal ranges (-17.5% - 57.04%), but the 
physiologic shunt fraction is elevated above normal reference ranges (0.7% – 8.8%).  Likewise, 
elevations in P(A-a)O2  in the COPD group above normal ranges after natural challenge is 
additional support that theses horses were experiencing gas exchange impairments.  Elevations in 
the physiologic shunt fraction indicates venous admixture of blood from poorly ventilated but 
adequately perfused alveoli with end-pulmonary capillary blood from normally functioning 
alveoli (McDonell 1996).  Bronchoconstriction and hyper-secretion of mucus, classic clinical 
signs of COPD, will result in inadequately ventilated and/or underperfused alveoli and thus 
elevations in the percent venous admixture (Qs/Qt) and alveolar-arterial oxygen difference (P(A-
a)O2 ) in horses with COPD.    Elevations of Vd/Vt within the COPD group and thus increased 
areas of hypoventilation within the lung, still help confirm that these horses were indeed 
experiencing an acute exacerbation of inflammatory airway disease.  Dexamethasone 
administration in the COPD horses was observed to cause a downward trend in Qs/Qt and Vd/Vt 
percentages bringing the values closer to their initial baseline values on Day 1.     49
 
Elevations in the neutrophil percent of BAL and transtracheal wash preparations are well 
documented in clinical cases of COPD.    This study is in support of this fact as the number of 
neutrophils increased dramatically from baseline to after antigenic challenge in the COPD group 
of horses.  A downward trend in neutrophil percent was observed with dexamethasone 
administration in both groups.  Decreases in macrophage and lymphocyte percentages in the 
COPD horses from baseline to after natural challenge were most likely a function of the increase 
in neutrophil percentages.  Increased circulating catecholamines from stress of the disease could 
have contributed to the lower lymphocyte percentage.  Additionally, peribronchial recruitment of 
both lymphocytes and possibly macrophages may have lowered the percentage recovered.   50
 Conclusion: 
Adaptation of the apoptotic methods Vindelov’s propidium iodide with Triton-X, 7-
aminoactinomycin-D, and Annexin-V/Propidium iodide indicated that all three methods were 
able to be successfully used in the horse.  Evaluation of the staining relationships between each 
stain for different time points in culture revealed that only the methods that preserve cell 
membrane integrity, 7-aminoactinomycin-D and Annexin-V/Propidium iodide, were comparable 
over time.  Vindelov’s propidium iodide with Triton-X destroyed the cell membrane and thus 
included all apoptotic cells with DNA fragmentation in the total apoptotic percent.  Alterations in 
the apoptotic staining ability of each stain was observed to be unaffected by disease state 
indicating that these stains can be used in COPD horses during all stages of disease and 
remission.  Therefore, when evaluating apoptosis in a heterogeneous population of cells, like 
those found in equine bronchoalveolar fluid, the 7-aminoactinomycin-D and Annexin/Propidiun 
iodide methods should be considered.   
 
Although no differences were seen in mean lymphocyte apoptosis between COPD and control 
horses before and after dexamethasone administration, this study is unable to definitively state 
there are no differences.  Numerical trends in the COPD horses did note a decrease in 
lymphocyte apoptosis after natural challenge when compared to the normal horses.  Small study 
size, wide horse to horse variability, and sampling of a heterogeneous population including 
phagocytic cells could have contributed to any lack of differences.  Potentially, we should be 
targeting our efforts at the T lymphocytes that infiltrate the peribronchial tissues instead of the 
bronchoalveolar area.  Additional work to identify the most appropriate population of cells and 
methods to purify them are needed at this time. 
 
Dexamethasone administration was associated with significant improvements in the physiologic 
shunt fraction and trends of improvement in alveolar dead space fractions indicating improved 
pulmonary gas exchange due to decreased shunting of blood away from underperfused alveoli.  
Additionally BAL cytologic trends of improvements were seen with decreasing numbers of 
neutrophils with more normal numbers of macrophages and lymphocytes.  Increasing trends in 
lymphocyte apoptosis in the COPD group was observed after dexamethasone administration. 
These trends paralleled clinical signs of recovery in the COPD horses.  The trends observed in   51
the COPD horses including the decreased apoptosis after natural challenge and improvements 
more toward baseline apoptosis after dexamethasone needs further exploration.   
 
   52
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APPENDIX A:  
Calculation of Physiologic Shunt Fraction 
Qs/Qt  =  (Cc’O2 - CaO2) 
                (Cc’O2 - Cv O2)               
 
(Cc’O2 : Alveolar oxygen content; CaO2 : arterial blood oxygen content; CvO2 : venous 
blood oxygen content) 
 
Calculation of the Alveolar Dead Space Fraction 
Vd/Vt  =  (paCO2 – ETCO2)  
                     paCO2 
(paCO2 : arterial carbon dioxide tension; ETCO2 : end tidal CO2 tension of expired gas) 
 
 
Calculation of the Partial Pressure of Oxygen in the Alveolus 
pAO2 : (BP – PH20) x FiO2 – paCO2 
                                                 R 
(pAO2 :Alveolar oxygen tension; BP: barometric pressure; PH20 : partial pressure of water 
vapor at body temperature; FiO2 : inspired O2 fraction; R: respiratory exchange ration 
assumed to be 0.85) 
 
 
 
 Appendix B:  Example of murine thymocyte apoptosis at time 4 hours
Representative histograms of murine thymocytes were analyzed by 7-AAD, Annexin/PI and PI/
triton-X.  For 7-AAD, three fluorescent peaks were determined: dull (live), intermediate (early
apoptosis), and bright (late apoptosis/necrosis) staining forward (FSC) versus side scatter (SSC)
histograms.  For Annexin/PI, four distinct populations were identified based on Annexin-/PI-
(live), Annexin+/PI- (early apoptosis), Annexin+/PI+ (late apoptosis), and Annexin-/PI+ (necrotic)
staining.  For Propidium iodide with Triton-X, dull fluorescence identified late apoptosis and
bright fluorescence identified live cells. The FSC versus SSC setting were standardized for all
analysis.  The percentage of fluorescence on the gated population is reported for each stain. All
gates were standardized for all analysis.
64Appendix C:  Equine BAL lymphocyte apoptosis at time 4 hours:
Representative histograms of equine BAL lymphocytes were analyzed by 7-AAD, Annexin/PI
and PI/triton-X.  For 7-AAD, three fluorescent peaks were determined: dull (live), intermediate
(early apoptosis), and bright (late apoptosis/necrosis) staining forward (FSC) versus side scatter
(SSC) histograms.  For Annexin/PI, four distinct populations were identified based on Annexin-/
PI- (live), Annexin+/PI- (early apoptosis), Annexin+/PI+ (late apoptosis), and Annexin-/PI+ (ne-
crotic) staining.  For Propidium iodide with Triton-X, dull fluorescence identified late apoptosis
and bright fluorescence identified live cells. The FSC versus SSC setting were standardized for
all analysis.  The percentage of fluorescence on the gated population is reported for each stain.
All gates were standardized for all analysis.
65Appendix D:  Equine BAL lymphocyte apoptosis at time 12 hours:
Representative histograms of equine BAL lymphocytes were analyzed by 7-AAD, Annexin/PI
and PI/triton-X.  For 7-AAD, three fluorescent peaks were determined: dull (live), intermediate
(early apoptosis), and bright (late apoptosis/necrosis) staining forward (FSC) versus side scatter
(SSC) histograms.  For Annexin/PI, four distinct populations were identified based on Annexin-/
PI- (live), Annexin+/PI- (early apoptosis), Annexin+/PI+ (late apoptosis), and Annexin-/PI+ (ne-
crotic) staining.  For Propidium iodide with Triton-X, dull fluorescence identified late apoptosis
and bright fluorescence identified live cells. The FSC versus SSC setting were standardized for
all analysis.  The percentage of fluorescence on the gated population is reported for each stain.
All gates were standardized for all analysis.
66Appendix E:  Equine BAL lymphocyte apoptosis at time 24 hours:
Representative histograms of equine BAL lymphocytes were analyzed by 7-AAD, Annexin/PI
and PI/triton-X.  For 7-AAD, three fluorescent peaks were determined: dull (live), intermediate
(early apoptosis), and bright (late apoptosis/necrosis) staining forward (FSC) versus side scatter
(SSC) histograms.  For Annexin/PI, four distinct populations were identified based on Annexin-/
PI- (live), Annexin+/PI- (early apoptosis), Annexin+/PI+ (late apoptosis), and Annexin-/PI+ (ne-
crotic) staining.  For Propidium iodide with Triton-X, dull fluorescence identified late apoptosis
and bright fluorescence identified live cells. The FSC versus SSC setting were standardized for
all analysis.  The percentage of fluorescence on the gated population is reported for each stain.
All gates were standardized for all analysis.
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APPENDIX F:  Table of physical exam parameter means and ranges for control and 
COPD horses at baseline, after natural challenge and after dexamethasone therapy. 
 
 
 
 
Means are calculated from 4 control horses and 5 COPD horses. 
Group Day  Heart  Rate  Respiratory  Rate  Temperature 
Control  1  44 (40 –52)  17 (12 – 20)  99.2 (97.5 – 100.3) 
COPD  1  42 (36 – 48)  18 (16 – 24)  99.5 (99 – 100.2) 
Control  8  40 (36 – 44)  21 (12 –32)  99.3 (98.7 – 99.9) 
COPD  8  44.8 (36 – 72)  29 (12 – 48)  100.4 (99.3 – 102.7) 
Control  12  40 (36 – 44)  18 (8 – 28)  99 (98.2 – 100) 
COPD  12  44.8 (40 – 48)  25 (16 – 36)  99 (98.5 – 99.5)   69
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